-
Recent Posts
Categories
- Anesthesiology
- Avandia
- Biomedical Engineering
- Cardiology
- Clinical Trials
- Clinics
- Consumer Products
- Counterfeit Products
- Critical Care Medicine
- Dentistry
- Dermatology
- Emergency Rooms
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA 2013
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Home Care
- Hospitals
- Infectious Disease
- Internal Medicine
- Laboratory
- multiple sclerosis (MS)
- Nephrology
- Neurology
- Nursing
- OBGYN
- Oncology
- Ophthalmology
- Orthopaedic Surgery
- Pain Management
- Patients
- Pediatrics
- Pharmacy
- Physical Medicine
- Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Risk Manager
- Surgery
- Uncategorized
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
Tag Archives: Actoplus Met
May 2012 Safety Labeling Changes
Translation The MedWatch May 2012 Safety Labeling Changes posting includes 41 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and PATIENT PACKAGE INSERT. The “Summary Page” provides a listing of drug names … Continue reading
Posted in FDA 2012, FDA Label Change
Tagged 0.5% chlorhexidine gluconate solution and 70% isopropyl alcohol w/w, 2% Chlorhexidine Gluconate, 4% w/v chlorhexidine gluconate, Aciphex, Actoplus Met, Aredia, Avagard Surgical and Healthcare Personnel Hand Antiseptic, benazepril, Biaxin Filmtabs, Biaxin Granules, Biaxin XL Filmtabs, brand of iopromide, Catapres, Catapres-TTS, CHG, Chlorascrub Swabsticks, chlorhexidine gluconate 1% solution and ethyl alcohol 61% w/w, chlorhexidine gluconate 2% and 4%, clarithromycin extended release tablets, clarithromycin for oral suspension, clarithromycin tablets, clonidine, clonidine hydrochloride, Delayed-Release Tablets, Dexilant, dexlansoprazole, dexmethylphenidate hydrochloride, Divigel, Drug Safety Communication, estradiol gel, ethosuximide, FDA notice, Fingolimod, Focalin, Focalin XR, Folotyn, For Delayed-Release Oral Suspension, Gilenya, Hibiclens, Hibistat, Injection Pharmacy Bulk Pack, lansoprazole, Lotensin, May 2012 Safety Labeling Changes, Omeprazole/Sodium Bicarbonate/Magnesium Hydroxide Tablets, pamidronate disodium, pantoprazole sodium, pantoprazole sodium For Injection, pioglitazone hydrochloride plus metformin hydrochloride, pralatrexate injection, Prevacid, PRotonix, rabeprazole sodium, safety label changes, Scrub-Stat 2% and Scrub-Stat 4%, Transdermal Therapeutic System, Ultravist, USP), Zarontin
Comments Off